Performance measure summary reports

Paul Coverdell National Acute Stroke Registry Quarterly Performance Measure Results
Number of Hospitals:
Demographic	N*	Percent*
Age
18-34
35-44
45-54
55-64
65-74
75-84
85+
Race
Non-Hispanic White
Non-Hispanic Black
Hispanic
Other
Unknown
Gender
Missing
Male
Female
Arrival Mode	N*	Percent*
EMS
Private Auto
Transfer From Another Hospital
ND/Unknown
Type	N*	Percent*
Ischemic
ICH
SAH
TIA
Ill-Defined (SNS)
No stroke
Missing
Alteplase (tPA)	N*	Percent*
All IS Patients receiving any tPA
All IS tPA patients having symptomatic ICH complications
All IS tPA patients having life threatening complications
Door to needle time <=45 minutes
Mean Door to Needle Time (hours)
Median Door to Needle Time (hours)
Mean LKW to Needle Time (hours)
Median LKW to Needle Time (hours)

TIA only & SNS only	N*	Percent*
TIA Patients who received any tPA
SNS Patients who received any tPA

Coverdell In-Hospital Performance Measures Numerator*				Denominator*	Percent*	HS/SNS	IS	TIA
Alteplase (tPA) Given							X
Dysphagia Screening						X	X
VTE/DVT Prophylaxis by end of Day 2						X	X
Antithrombotic Therapy by end of Day 2							X	X
Assessed for Rehabilitation						X	X
Stroke Education						X	X	X
Smoking Cessation Counseling						X	X	X
Antithrombotic Therapy at Discharge							X	X
Statin Therapy at Discharge							X	X
Anticoagulation for Atrial Fibrillation							X	X
Doo to needle (IV tPA) time in 60 minutes							X
NIH stroke scale score recorded							X
Ischemic Stroke Only			Numerator*	Denominator*	Percent*	White*	Race Other*	Male*	Female*
Alteplase (tPA) Given
Dysphagia Screening
VTE/DVT Prophylaxis by end of Day 2
Antithrombotic Therapy by end of Day 2
Assessed for Rehabilitation
Stroke Education
Smoking Cessation Counseling
Antithrombotic Therapy at Discharge
Statin Therapy at Discharge
Anticoagulation for Atrial Fibrillation
Door to needle (IV tPA) time in 60 minutes
NIH stroke scale score recorded
TIA Only			Numerator*	Denominator*	Percent*	White*	Race Other*	Male*	Female*
Antithrombotic Therapy by end of Day 2
Stroke Education
Smoking Cessation Counseling
Antithrombotic Therapy at Discharge
Statin Therapy at Discharge
Anticoagulation for Atrial Fibrillation
Hemorrhagic Stroke Only			Numerator*	Denominator*	Percent*	White*	Race Other*	Male*	Female*
Dysphagia Screening
VTE Prophylaxis by end of Day 2
Assessed for Rehabilitation
Stroke Education
Smoking Cessation Counseling
Defect free care	Numerator*	Percent*
Ischemic inpatient
Ischemic discharge
Hemorrhagic
TIA
Data source: , All are weighted estimated
Centers for Disease Control and Prevention - Division for Heart Disease and Stroke Prevention

Pre hospital performance measures (drafted 8 measures)
% of stroke transports with an on-scene time<15 minutes
% of stroke transports with a blood glucose checked and recorded
% of stroke transports where EMS called in a stroke alert pre-notification
% of stroke transports that had a stroke screen completed and recorded
% of stroke transports that had a documented the time last known to be well
% of stroke transports that had a documented time of discovery
% of stroke transports that had a thrombolytic stroke check completed and documented
% of stroke transports where EMS diagnosis agreed with hospital diagnosis
Post-hospital Measures (drafted 9 measures)
% of stroke patients discharged to home who have died by 30 days
% of stroke patients who were seen in ED within 30 days of discharge
% of stroke patients who were readmitted to the hospital within 30 days of discharge
% of stroke patients reporting blood pressure (BP) > 140 systolic or > 90 diastolic among those checking their BP at home
% of stroke patients checking the BP at home
% of stroke patients reporting 2 or more falls within 30 days of discharge
% of stroke patients who stopped taking medications since discharge
% of stroke transports where EMS diagnosis agreed with hospital diagnosis
% of stroke patients that had a follow-up appointment scheduled prior to discharge
Adherence to the performance measures
% adherence to Coverdell patient-level performance measures of care for EMS
% adherence to Coverdell patient-level performance measures of care for in-hospital and transition of care
% of patients with defect-free in-hospital care by stroke type
% of patients with defect-free care by EMS
Data source: Centers for Disease Control and Prevention - Division for Heart Disease and Stroke Prevention

27